Found 17 results
Author Title [ Type(Desc)] Year
Filters: Author is Atmar, Robert L  [Clear All Filters]
Journal Article
Mbawuike, I. N., Atmar, R. L., Patel, S. M., Corry, D. B., Winokur, P. L., Brady, R. C., et al.. (2016). Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine. Vaccine, 34(4), 547-554. presented at the 2016 Jan 20. doi:10.1016/j.vaccine.2015.11.055
Atmar, R. L., Opekun, A. R., Gilger, M. A., Estes, M. K., Crawford, S. E., Neill, F. H., et al.. (2014). Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis, 209(7), 1016-22. presented at the 2014 Apr 01. doi:10.1093/infdis/jit620
Atmar, R. L., Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., et al.. (2011). Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med, 365(23), 2178-87. presented at the 2011 Dec 08. doi:10.1056/NEJMoa1101245
Keitel, W. A., Piedra, P. A., Atmar, R. L., Demmler, G., Sahly, H. M. El, Barrett, J., et al.. (2013). Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised). BMC Res Notes, 6, 177. presented at the 2013 May 03. doi:10.1186/1756-0500-6-177
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., et al.. (2020). Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med. presented at the 2020 May 22. doi:10.1056/NEJMoa2007764
Sahly, H. M. El, Atmar, R. L., Patel, S. M., Bellamy, A., Liu, L., Hong, W., et al.. (2019). Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination. Vaccine, 37(19), 2561-2568. presented at the 2019 05 01. doi:10.1016/j.vaccine.2019.03.071